Biocon, a leading biopharmaceuticals major from Bangalore, has suffered setback during the second quarter ended September 2008 and its consolidated net profit after exceptional items declined sharply by 53.6 per cent to Rs 25.02 crore from Rs 53.95 crore in the corresponding period of last year.
The details can be read here.
No comments:
Post a Comment